Preclinical Immunotherapy Combination Protocol
Corresponding Organization : The University of Texas MD Anderson Cancer Center
Other organizations : Shanghai Jiao Tong University, Shanghai First People's Hospital, The University of Texas Health Science Center at Houston, Bellicum Pharmaceuticals (United States)
Variable analysis
- Anti-mouse PD-1 (clone RMP1-14)
- Anti-mouse CTLA-4 (clone 9D9)
- Anti-mouse CD80 (clone 16-10A1)
- Anti-mouse CD86 (clone GL-1)
- Anti-mouse Ly6C (clone Monts 1)
- Anti-mouse CCL2 (clone 2H5)
- Recombinant murine CCL2 (catalog #250-10)
- Recombinant murine IFN-γ (catalog #315-05)
- Recombinant murine IL4 (catalog #214-14)
- Recombinant murine GM-CSF (catalog #315-03)
- Recombinant murine M-CSF (catalog #315-02)
- Dependent variables not explicitly mentioned.
- Isotype-matched IgG controls
- Positive controls: Isotype-matched IgG controls
- Negative controls: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!